Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CRE8 in All Comers Patients

NCT01687075 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.

NCT NCT01687075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01687075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CRE8 in All Comers Patients
Lead sponsor
Tel-Aviv Sourasky Medical Center
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2012
Completion date
August 31, 2014
Enrollment
215 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

a total number of 200 patients fulfilling the selection, angioplasty of de novo lesion(s) in native coronary, arteries should be screened for eligibility., be enrolled in the trial., consecutive subjects who are suitable for a coronary, criteria and willing to sign the informed consent should